✦ LIBER ✦

Current and future treatments in progressive supranuclear palsy

✍ Scribed by Irene van Balken; Irene Litvan

Publisher: Springer
Year: 2006
Tongue: English
Weight: 724 KB
Volume: 8
Category: Article
ISSN: 1092-8480
DOI: 10.1007/s11940-006-0012-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Toward future therapies in progressive s

Toward future therapies in progressive supranuclear palsy

✍ David J. Burn; Naomi M. Warren 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

There is a stern therapeutic challenge for progressive supranuclear palsy (PSP) that has not yet been met. The lack of randomized, controlled trials and negative outcomes from the vast majority of studies make it impossible to set therapeutic standards, or to give clear recommendations. We review pr

Physostigmine treatment of progressive s

Physostigmine treatment of progressive supranuclear palsy

✍ Irene Litvan; Claudia Gomez Med; John R. Atack; Marjorie Gillespie; Anne M. Kask 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 457 KB 👁 2 views

Hyposmia in progressive supranuclear pal

Hyposmia in progressive supranuclear palsy

✍ Laura Silveira-Moriyama; Graham Hughes; Alistair Church; Hilary Ayling; David R. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 239 KB

## Abstract Previous studies suggested that olfaction is normal in progressive supranuclear palsy (PSP). We applied the University of Pennsylvania Smell Identification Test (UPSIT) to 36 patients with PSP who scored more than 18 on the Mini Mental State Examination (MMSE), 140 patients with nondeme

Treatment of progressive supranuclear pa

Treatment of progressive supranuclear palsy and corticobasal degeneration

✍ Anthony E. Lang 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB

Success in treating patients with progressive supranuclear palsy and corticobasal degeneration remains exceedingly low. This finding probably relates to the widespread distribution of the pathological changes that account for the varied and complex spectrum of clinical manifestations. Dopaminergic d

Research goals in progressive supranucle

Research goals in progressive supranuclear palsy

✍ Irene Litvan; Dennis W. Dickson; Jean A. Buttner-Ennever; Andre Delacourte; Mike 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 2 views

Sleep abnormalities in progressive supra

Sleep abnormalities in progressive supranuclear palsy

✍ Dr. Michael S. Aldrich; Norman L. Foster; Roberta F. White; Laurie Bluemlein; Gr 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 453 KB 👁 2 views

We studied sleep patterns for three nights in 10 subjects with moderate to severe progressive supranuclear palsy and correlated the findings with disease severity using quantitative measures of motor, cognitive, abd eye movement impairment. All subjects had severe insomnia, spending 2 to 6 hours awa